Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment

By afschroeder • October 6, 2025

Fava A, Wagner CA, Guthridge CJ, Macwana S, DeJager W, Munroe ME, Izmirly P, Belmont HM, Diamond B, Davidson A, Utz PJ, Weisman MH, Carlucci PM, Dall'Era M, Kalunian K, Putterman C, Anolik J, Barnas JL, Wofsy D, Kamen D, Furie RA, Rao DA; Accelerating Medicines Partnership (AMP) RA/SLE Network; Petri M, Guthridge JM, Buyon J, James JA. Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment. Arthritis Care Res (Hoboken). 2025 Oct 6. doi: 10.1002/acr.25652. Epub ahead of print. PMID: 41048053.

Tags: Cedars Sinai DoM, Publications, Rheumatology

cGAS-STING dependent type I IFN reduces Leptospira interrogans renal colonization in mice

Gupta S, Matsunaga J, Ratitong B, Manion A, Ismaeel S, Valadares DG, West AP, Kerur N, Stehlik C, Dorfleutner A, Dagvadorj J, Coburn J, Wolf[...]

Design and Rationale of the WARRIOR Ancillary Study for Coronary CT Angiographic Analysis

Tamarappoo B, Wolny R, Tomasino GF, Berman D, Handberg E, Pepine CJ, Lo MC, Budoff M, Shaw L, Shufelt C, Wei J, Gulati M, Merz[...]

Public Health

Tan ZS, Qureshi N, Sicotte N, Escovedo C, Hirsch A, Afrashteh A, Miles PB, Roberts P. Public Health. Alzheimers Dement. 2025 Dec;21 Suppl 6(Suppl 6):e101651.[...]